Peptide
CJC-1295
CJC-1295 with DAC / Mod GRF 1-29
Research ChemicalHuman StudiesInjection (SubQ)
Half-life
~6-8 days (with DAC)
Common dose
1-2mg per week
How it works
GHRH analog with a Drug Affinity Complex (DAC) that extends half-life dramatically. Stimulates sustained GH release from the pituitary — best stacked with Ipamorelin for synergistic GH pulses.
Commonly used for
HGH stimulationMuscle massAnti-agingRecovery
Potential benefits
- Long half-life means fewer injections than other GHRH analogs
- Significant increase in IGF-1 levels over time
- Pairs powerfully with Ipamorelin for amplified GH output
- Improves sleep, recovery, and body composition
- Well studied among GH secretagogues
Risks and downsides
- DAC version causes 'GH bleed' — continuous release rather than pulsatile
- Water retention common
- Not FDA approved
- Suppresses natural GH axis with long-term use
- Requires refrigeration
Heads up: This is for educational purposes only and is not medical advice. Many compounds here are not FDA approved for human use. Please talk to a doctor before starting anything.
Risk level
Evidence
What you need to get started
Community experiences
Been there?
Sign in to share your experience with the community.
Loading reviews...